Harry J.F. Bloomfield

Harry J.F. Bloomfield is a declared insider of Algernon Pharmaceuticals Inc., with filings sourced from SEDI. Between 9 September 2021 and 5 February 2024, the trades on record add up to 12 filings.

Every open-market trade on record is a purchase: 6 purchases worth €286k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 option exercises.

In size, the median ticket on the buying side is €4,482. No cluster: in 6 purchases, no other insider of the company bought within 30 days.

Most recently, on 8 February 2024, the filings show an option exercise in Algernon Pharmaceuticals Inc. The last purchase on record was published on 17 April 2022, which is 1,652 days ago. The median gap between a trade and its publication by SEDI is 4 days. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.